MONTREAL, May 09, 2024 (GLOBE NEWSWIRE) — Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of innovative therapies, reported the voting results from its annual meeting of shareholders held today in a virtual-only setting.

Shareholders proceeded to elect the below candidates to the Company’s Board of Directors for a one-year term and appointed KPMG LLP as the Company’s auditors for the current fiscal year. All candidates proposed for the position of director were elected in the following proportion:

	FOR		% FOR		ABSTENTION		% ABSTENTION
Joseph Arena	22,405,047		93.09	%	1,663,754		6.91	%
Frank Holler	21,008,601		87.29	%	3,060,200		12.71	%
Paul Lévesque	20,966,427		87.11	%	3,102,374		12.89	%
Andrew Molson	21,067,050		87.53	%	3,001,751		12.47	%
Dawn Svoronos	20,964,213		87.10	%	3,104,588		2.90	%
Elina Tea	21,734,254		90.30	%	2,334,547		9.70	%
Dale Weil	21,009,681		87.29	%	3,059,120		12.71	%
Jordan Zwick	23,107,383		96.01	%	961,418		3.99	%

Frank Holler will now act as Chair of the Board of Directors of the Company.

About Theratechnologies

Theratechnologies (TSX: TH) (NASDAQ: THTX) is a biopharmaceutical company focused on the development and commercialization of innovative therapies addressing unmet medical needs. Further information about Theratechnologies is available on the Company’s website at www.theratech.com, on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov. Follow Theratechnologies on Linkedin and X (formerly Twitter).

Contacts:

Investor inquiries:
Philippe Dubuc
Senior Vice President and Chief Financial Officer
[email protected]
1-438-315-6608

Media inquiries:
Julie Schneiderman
Senior Director, Communications & Corporate Affairs
[email protected]
1-514-336-7800

Bay Street News